Moodify

Software-defined Scents

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in May 2017 by Yigal Sharon and Eyal Maor, Moodify operates with 11–50 employees. The company has raised a total of $19.3M across 4 funding rounds from 8 investors. In July 2026, Moodify Pet was welcomed into ADMC's product portfolio, expanding its distribution footprint.

Business overview

Moodify leverages neuroscience, bioinformatics, and machine-learning technology to innovate scent creation, aiming to deliver more effective, sustainable consumer products. Its technology streamlines scent design and manufacturing, making it more scalable, accurate, cost-effective, compliant, and rapid. The company operates within the Health Tech & Life Sciences sector, with applications in digital healthcare and automotive, serving markets across Europe, Japan, North America, and Israel.

Strategic signal

In July 2026, ADMC welcomed Moodify Pet into its product portfolio, significantly expanding Moodify's distribution footprint. This partnership signals strong commercial validation for Moodify's scent technology in the pet care market, indicating a strategic move towards broader consumer product integration and market reach for investors.

Company Intelligence Q&A

What was a significant recent partnership for Moodify?
In July 2026, ADMC welcomed Moodify Pet into its product portfolio, expanding Moodify's distribution footprint.
Which investors participated in Moodify's May 2022 funding round?
In May 2022, Moodify received funding from Philip Morris International and OurCrowd.
What was a key collaboration for Moodify in January 2020?
In January 2020, Moodify collaborated with Valeo to develop a solution for car malodor.
What technology does Moodify utilize for its scent solutions?
Moodify utilizes neuroscience, bioinformatics, and machine-learning technology to transform scent creation for consumer products.